Clinical study participation has historically been heavily biased toward specific demographics.
Several people will be invited to enroll in this trial so that it may collect a variety of data about uterine cancer clinical study experiences and identify barriers to participation as well as the causes of participants' failure or withdrawal.
People with uterine cancer who are invited to take part in medical study will benefit from the analysis of the data.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Aged ≥ 18 years old and ability to provide written informed consent obtained prior to participation in the study and any related procedures being performed
* Diagnosis of uterine cancer
* No prior treatment for uterine cancer
Exclusion Criteria:
* Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
* Enrolled in another research study
* Inability to provide written informed consent
Primary outcome measure(s)
Number of patients who decide to enroll in a uterine cancer clinical research — 3 months
Rate of patients who remain in a uterine cancer clinical trial to trial completion — 12 months
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time on our Cookie Policy page. See also our Privacy Policy.